Home
overview

SMi Group’s 7th annual Biosimilars Europe conference returns to London this September!

The development of the Biosimilars market is growing exponentially with the industry forecast to be worth $25 billion by 2020. With the regulatory landscape evolving rapidly, it is important to understand the developments in the biosimilar guideline framework and the cohesion in legislation between Europe and the US.

With Europe leading the way in the field of Biosimilar development, it is important to get to grips with all areas in the product lifecycle from early stage developments, protein characterisation and analytical comparability to patent litigation, market access, pricing and reimbursement through to emerging markets and global developments. Every angle should be considered and taken account for through the development process and with the EU the most advanced market for biosimilars, accounting for 80% of global spending on these molecules, the learning curve for biosimilars is essentially still building and there are hurdles to overcome.

  • HEAR the latest on the evolving regulatory biosimilar landscape and review the guidelines 
  • GAIN understanding on the barriers being faced for market access and commercialisation of products through case-study led presentations
  • FOCUS on the global market developments with case studies on Emerging Markets of biosimilars and assessing the trends we are currently seeing
  • ASSESS and review in-depth protein characterisation and analytical comparability to efficiently and effectively collect data
     

Job titles include but are not restricted to:
CSOs, CMOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, from the following roles:
• Biopharmaceuticals/ Biotherapeutics
• Follow on Biologics/Follow on Proteins/Biosimilars
• Biologics/Biotechnology/ Biogenerics
• Legal and Regulatory Affairs
• Intellectual Property
• Health Economics
• Pricing and Reimbursement
• Clinical Immunology
• Process Control and Analytical Technologies
• Analytical Characterisation
• Regulatory Compliance
• Pharmacovigilance
• Drug Safety & Risk Management
• Quality Affairs/ Quality Control
• New Product Development
• Process Science
• Portfolio Management
• Research & Development
• Business Development
• Business Operations
• Scientific Affairs
• Commercial Affairs and Strategic Planning
• Legislation and Policy Advice

AbbVie Ltd; Anteris Medical GmbH; aris; Arnold & Porter; Arnold and Porter; Boehringer Ingelheim Pharma GmbH & Co KG; Bristows; Cinfa Biotech; Ecole Normale Supérieure de Cachan; Eppendorf AG; GenericsWeb; GfK HealthCare; Globyz Pharma; Grifols America Inc; IMS Health UK; Independant Consultant; Invest Lithuania; Italfarmaco Spa; Kantar Health; Kinesys Consulting Ltd; Merck Serono; MHRA; Mundipharma International Ltd; Myoderm; Newcastle University; Norwegian Medicines Agency; Orion Corporation; Pharmavision; SAI MedPartners; Sandoz International Gmbh; Sanofi; Schwegman Lundberg Woessner; Selecta Biosciences; SGS M-Scan Ltd.; SGS M-Scan SA; SGS United Kingdom Ltd.; Teva Pharmaceutical Works Ltd; TEVA pharmacuetical ind.; Thermo Fisher Scientific; Thomson Reuters; University Of Basel; University Of The Basque Country; Venner Shipley L L P; Wyatt Health Management;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Virginia Acha

Virginia Acha, Executive Director and Research, Medical and Innovation, ABPI

9:10 Biosimilars: The next decade!

Duncan Emerton

Duncan Emerton, Senior Director, Syndicated Insights & Analysis, FirstWord

  • Achievements: in 2016 we are celebrating ten years of biosimilars, but what have we really achieved?
  • Strategies & tactics: Who's doing what in biosimilars, where and how can biosimilar companies translate clinical and scientific excellence into a healthy return?
  • Myths & truths: Pulling back the curtain on some of the most common misunderstandings in the biosimilars market
  • The next decade: Looking beyond Europe, predicting what will happen in the US, mapping the next targets for biosimilar development
  •  

    9:50 The effects of biosimilar competition across Europe

    Ad  Rietveld

    Ad Rietveld, Director, RJW & partners Ltd

  • Biological medicines market underpins the potential for healthcare savings and increased access
  • Product availability in each therapeutic area
  • Correlation between biosimilars market share and price erosion of biological medicines
  • Potential for significant savings associated with increased competition
  • 10:30 Morning Coffee

    11:00 The importance of early immunogenicity and Product Quality (PQA) assessment in biosimilar development

  • Understanding the causes and variations of immunogenicity between biosimilars and originators
  • Case study: EPO vs infliximab switching experiences
  • Methods for preclinical immunogenicity and PQA assessment for early comparative analysis 
  • De-risking approaches for biosimilars and biobetters
  • Laura Perry

    Laura Perry, Director of Scientific Affairs, Cell Line Development, Abzena

    11:40 Strategies to enter the emerging markets

    Huiguo Hu

    Huiguo Hu, General Manager of International Business, Shanghai CP Guojian Pharmaceutical Co. Ltd

  • Regulation situation and guidelines listing
  • Pricing and reimbursement
  • Challenges and key success factors
  • 12:20 Networking Lunch

    13:30 Biosimilars – the second translational gap

    Virginia Acha

    Virginia Acha, Executive Director and Research, Medical and Innovation, ABPI

  • Incorporating biosimilars into healthcare practice is the next translational challenge
  • In the UK, NHS England leads a multi-stakeholder coordinating group to address this
  • Success through training and guidance and effective competition is delivering results
  • 14:10 CASE STUDY: The emerging biosimilars asset class – strategy & portfolio management in a VUCA (Volatile, Uncertain, Compex & Ambiguous) world

    Atanas Dimitrov

    Atanas Dimitrov, Head of Strategy & Portfolio Management, Merck Group

  • Optimally leverage the unique characteristics of the biosimilars asset class:

                         -the lower risk vs original biologics while in a steady state expecting higher margin then in consumer healthcare
                         -the unique breadth of options for in-licensing compared to novel pharmaceuticals, i.e. potential to secure more shots at the goal

  • Create a strategically agile organizational set-up for biosimilars with a high degree of decision autonomy, strong & long-term commitment from senior management 
  • 14:50 Afternoon Tea

    15:20 Recent trends in the development of biosimilars and evaluation of analytical biosimilarity

    Luis Borlido

    Luis Borlido, Lab Head Characterization, Sandoz International GmBH

  • QbD driven development. Strategies for criticality assessment
  • Statistical similarity data evaluation
  • Challenges of equivalence testing
  • 16:00 Biologics and biosimilars: Trends and challenges

    Alan Sheppard

    Alan Sheppard, Principal, Global generics and biosimilars, IMS Health

  • Drivers and penetration across different markets
  • Therapeutic positioning and need for cost savings
  • Effect of competition, originator response and first to market opportunities
  • 16:40 Analytical Strategies in biosimilar development

    Alok Sharma

    Alok Sharma, Principal Scientist & Head Analytical Development , Lupin Limited

  • Challenges in biosimilar similarity assessment
  • Residual uncertainty
  • Newer analytical technologies
  • Statistical considerations
  • 17:20 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Virginia Acha

    Virginia Acha, Executive Director and Research, Medical and Innovation, ABPI

    9:10 European regulatory update for biosimilars

    Andrea Laslop

    Andrea Laslop, Head of Scientific Office, Austrian Agency for Health and Food Safety

  • Latest revisions of biosimilar guidelines
  • How much clinical evidence do we need
  • Lessons learned from recent approvals in Europe
  • 9:50 How can you beat the shark: end around play for the us legal battle of pharma and biotech

    Jim Nelson

    Jim Nelson, Senior Shareholder and Principal, Schwegman Lundberg Woessner

  • Traditional and new market view – worldwide
  • Alternative to BPCIA –biosimilars in USA
  • Mapping and use of IPR offensively and defensively (guide for IPR proof patents) – USA legal
  • Think BioBetters!!!! – YOU WIN
  • 10:30 Morning Coffee

    11:00 Regulatory Science Ireland: Biosimilars research project

    Joan O'Callaghan

    Joan O'Callaghan, Research Scientist for Regulatory Science Ireland, Health Products Regulatory Authority

  • Prescriber attitudes and behaviours towards biosimilar medicines
  • Reducing the information gap
  • Comparison of international models for providing safe and effective supply of biosimilar medicines
  • 11:40 KEYNOTE ADDRESS: From biosimilars to biogenerics?

    Steinar Madsen

    Steinar Madsen, Medical Director, Norwegian Medicines Agency

  • Uptake of biosimilars in clinical practice
  • The importance of switching
  • Switching - clinical trials and practical experiences
  • 12:20 Networking Lunch

    13:30 Litigation update: Europe and the US

    Dominic Adair

    Dominic Adair, Partner, Bristows LLC

  • A look at the latest biosimilar litigation cases from the UK and the US
  • Assessing the drivers, strategy and outcomes
  • Looking ahead to future disputes and a new European landscape: the Unified Patent Court
  • 14:10 KEYNOTE ADDRESS: Robust Pharmacovigilance: A key to successful biosimilars

    Niraj Chhaya

    Niraj Chhaya, Senior Risk Management Physician, Boehringer Ingelheim GmbH

  • Guidelines for biosimilar pharmacovigilance in the EU and USA
  • Key considerations: Immunogenicity, interchangeability, traceability
  • Risk management plans for biosimilars
  • 14:50 Afternoon Tea

    15:20 The increasing importance of medical devices for regulatory and commercial success of biosimilars

    Dirk Kreder

    Dirk Kreder, Founder and CEO, Anteris Medical GmbH

  • Biosimilars offer very few opportunities for differentiation
  • Autoinjectors and other medical device components are the only area, where biosimilars can offer additional value and differentiate
  • Originators and biosimilar developers are facing an “arms race” with medical devices to secure
  • 16:00 Looking for fingerprints

    16:40 Chairman’s Closing Remarks and Close of Day Two

    +

    FEATURED SPEAKERS

    Andrea Laslop

    Andrea Laslop

    Head of Scientific Office, Austrian Agency for Health and Food Safety
    Atanas Dimitrov

    Atanas Dimitrov

    Head of Strategy & Portfolio Management, Merck Group
    Huiguo Hu

    Huiguo Hu

    General Manager of International Business, Shanghai CP Guojian Pharmaceutical Co. Ltd
    Joan O'Callaghan

    Joan O'Callaghan

    Research Scientist for Regulatory Science Ireland, Health Products Regulatory Authority
    Niraj Chhaya

    Niraj Chhaya

    Senior Risk Management Physician, Boehringer Ingelheim GmbH

    Ad Rietveld

    Director, RJW & partners Ltd
    Ad  Rietveld

    Alan Sheppard

    Principal, Global generics and biosimilars, IMS Health
    Alan Sheppard

    Alok Sharma

    Principal Scientist & Head Analytical Development , Lupin Limited
    Alok Sharma

    Andrea Laslop

    Head of Scientific Office, Austrian Agency for Health and Food Safety
    Andrea Laslop

    Atanas Dimitrov

    Head of Strategy & Portfolio Management, Merck Group
    Atanas Dimitrov

    Dirk Kreder

    Founder and CEO, Anteris Medical GmbH
    Dirk Kreder

    Dominic Adair

    Partner, Bristows LLC
    Dominic Adair

    Duncan Emerton

    Senior Director, Syndicated Insights & Analysis, FirstWord
    Duncan Emerton

    Huiguo Hu

    General Manager of International Business, Shanghai CP Guojian Pharmaceutical Co. Ltd
    Huiguo Hu

    Jim Nelson

    Senior Shareholder and Principal, Schwegman Lundberg Woessner
    Jim Nelson

    Joan O'Callaghan

    Research Scientist for Regulatory Science Ireland, Health Products Regulatory Authority
    Joan O'Callaghan

    Laura Perry

    Director of Scientific Affairs, Cell Line Development, Abzena
    Laura Perry

    Luis Borlido

    Lab Head Characterization, Sandoz International GmBH
    Luis Borlido

    Niraj Chhaya

    Senior Risk Management Physician, Boehringer Ingelheim GmbH
    Niraj Chhaya

    Steinar Madsen

    Medical Director, Norwegian Medicines Agency
    Steinar Madsen

    Virginia Acha

    Executive Director and Research, Medical and Innovation, ABPI
    Virginia Acha

    Sponsors and Exhibitors

    Official Media Partner

    Official Publication

    Official Online Media Partners

    Supporters

    Workshops

    Maximisation of IP Regulatory Rights
    Workshop

    Maximisation of IP Regulatory Rights

    Holiday Inn Kensington Forum
    28th September 2016
    London, United Kingdom

    How is the payer environment for biosimilars evolving?
    Workshop

    How is the payer environment for biosimilars evolving?

    Holiday Inn Kensington Forum
    28th September 2016
    London, United Kingdom

    VENUE

    Holiday Inn Kensington Forum

    97 Cromwell Road , London, United Kingdom

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    Snapshot of Previous Attendees

    Download

    Sponsors and Exhibitors


    Abzena

    Sponsors and Exhibitors
    http://www.abzena.com

    Abzena offers a suite of complementary services and technologies. Its range of technologies include immunogenicity assessment, antibody drug conjugation, protein engineering, PEGylation, cell line development , GMP manufacturing and a range of bespoke assays to enables the development of better biopharmaceuticals which will have a greater chance of reaching the market.


    Schwegman, Lundberg & Woessner

    Sponsors and Exhibitors
    http://www.slwip.com/

    Schwegman Lundberg & Woessner is a nationally recognized boutique IP firm focused on strategic patent procurement with over 140 patent practitioners that have robust backgrounds across a wide spectrum of technology areas. Schwegman's clients include multinational corporations, middle-market businesses, universities, as well as start-ups and individual inventors.

    Media Partners


    Generics Bulletin

    Official Media Partner
    https://www.generics-bulletin.com/

    Generics bulletin provides its subscribers with up-to-date commercial intelligence about business opportunities in the global generic medicines and biosimilars markets. Accurate and reliable news reports reveal the strategies of the world’s leading generics companies and analyse their business performance, plans and product portfolios. Patent and pricing issues, regulatory changes, government initiatives, market opportunities and industry consolidation provide the wider context for Generics bulletin’s comprehensive industry coverage. With subscribers in nearly 60 countries, Generics bulletin is read by senior executives in all of the world’s leading generics companies, as well as by industry watchers and those supplying active ingredients, goods and services to the global generic and biosimilar medicines industries.


    GaBi

    Official Media Partner
    http://www.gabionline.net

    GaBI Online was first launched in 2009 and has quickly developed into an authoritative resource for global news on the recent developments in the field of generics and biosimilars, a repository of worldwide guidelines and an archive of related scientific information. It seeks to provide readers with the latest updates on developments in relation to generic and biosimilar medicines, and to serve as a communication vehicle to reach key members of the healthcare world. GaBI Online subscribers can stay informed by receiving free weekly online alerts on the latest news on generic and biosimilar medicines from different perspectives covering information on research and general news, policies and legislation, worldwide guidelines, scientific and interview reports, news and reports of major conferences and events. GaBI Online is committed to the highest editorial and ethical standards in the provision of all its content and related services, and to providing objective and trustworthy information and guidance on all aspects of cost-effective health and health care. All content on GaBI Online is based on peer reviewed, scientific research articles, up-to-date legislation and other news sources selected by the editors and Publisher. We strive to provide evidence-based information in an easy-to-understand and easy-to-find format. GaBI Online consults widely with the relevant professional bodies and other interest groups in order to serve our audience of healthcare professionals. GaBI Journal’s International Editorial Advisory Board consists of over 32 respected experts from 19 countries in the field who provide regular input on issues relating to the content of GaBI Online.


    Biosimilar News

    Official Media Partner
    http://www.biosimilarnews.com

    BiosimilarNews.com is a leading international knowledge and information source about biosimilars. The site helps the industry professionals, clinicians and also the public to find timely and appropriate information about this specific area. Biosimilar News - We keep you up to date.

    Media Partners


    International Journal of Computational Biology and Drug Design

    Official Publication
    http://www.inderscience.com/ijcbdd

    IJCBDD, an International Society of Intelligent Biological Medicine official journal, bridges the gap between two very important, complementary disciplines, computational biology and drug design. Through advances in high-throughput genome sequencing and digital imaging technologies, biocomputing, drug design and medical research have unfolded new, predictive sciences such as genomics, proteomics, lipidomics, metabolomics, cytomics and pharmaconomics. These promote new computational, statistical and biomedical approaches to drug design/development, besides unleashing the potential of significantly more accurate, effective personalised diagnosis, therapeutics and patient care.


    International Journal of Biotechnology

    Official Publication
    http://www.inderscience.com/ijbt

    IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.


    International Journal of Medical Engineering and Informatics

    Official Publication
    http://www.inderscience.com/ijmei

    IJMEI promotes an understanding of the structural/functional aspects of disease mechanisms and the application of technology towards the treatment/management of such diseases. It seeks to promote interdisciplinary collaboration between those interested in the theoretical and clinical aspects of medicine and to foster the application of computers and mathematics to problems arising from medical sciences. IJMEI includes authoritative review papers, the reporting of original research, and evaluation reports of new/existing techniques and devices. Each issue also contains a comprehensive information service.


    International Journal of Bioinformatics Research and Applications

    Official Publication
    http://www.inderscience.com/ijbra

    Bioinformatics is an interdisciplinary research field that combines biology, computer science, mathematics and statistics into a broad-based field that will have profound impacts on all fields of biology. The emphasis of IJBRA is on basic bioinformatics research methods, tool development, performance evaluation and their applications in biology. IJBRA addresses the most innovative developments, research issues and solutions in bioinformatics and computational biology and their applications.

    Media Partners


    The Pharma Letter

    Official Online Media Partners
    http://www.thepharmaletter.com/

    The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, backed by a team of respected writers with many years of experience in the field.

    Media Partners


    Bentham Science

    Supporters
    http://www.benthamscience.com/

    Bentham Science Publishers is a major STM journal publisher of 116 titles and 200 plus open access journals and print/online book series (Bentham eBooks). Bentham Science answers the information needs of the pharmaceutical and biomedical research community. Leading journals include Current Drug Metabolism (Impact Factor 5.113) and Current Medicinal Chemistry (Impact Factor 4.859): FREE online journals and information: www.benthamscience.com


    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


    GBI

    Supporters
    http://www.gbihealth.com/

    GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


    American Pharmaceutical Review

    Supporters
    http://www.americanpharmaceuticalreview.com

    American Pharmaceutical Review is the leading review of business and technology for the pharmaceutical industry throughout North America. Each issue offers unbiased editorial on drug delivery, information technology, research & development, analytical development and control, equipment and facility manufacturing and regulatory affairs. American Pharmaceutical keeps its 30,000 readers including senior executives, technical personnel, scientists, and others fully abreast of the latest trends and developments in the process of pharmaceutical manufacturing.


    European Biotechnology Network

    Supporters
    http://european-biotechnology.net/

    The European Biotechnology Network is dedicated to facilitating co-operation between professionals in biotechnology and the life sciences all over Europe. The non-profit organisation brings research groups, universities, SMEs, large companies and indeed all actors in biotechnology together to build and deliver partnerships.


    CanBiotech

    Supporters
    http://www.canbiotech.com

    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.


    PMR

    Supporters
    http://www.pmrcorporate.com

    PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    Labhoo

    Supporters
    http://www.labhoo.com



    Thomson Reuters

    Supporters
    http://thomsonreuters.com/products_services/science/

    Thomson Reuters is the leading source of intelligent information for professionals around the world. We provide essential information to keep you in touch with the rapidly-changing pharmaceutical and chemical markets, expert services to help you make informed, early decisions, and intuitive technology to manage and support your discovery and development activities. Our products give you the intelligence, tools and expertise to help you optimize your IP portfolio, monitor industry developments, identify licensing and partnering opportunities, deliver successful regulatory submissions, and support your scientific messaging, marketing, product positioning, and awareness campaigns.


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    International Pharmaceutical Industry

    Supporters
    http://www.ipimediaworld.com

    IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.


    FirstWord

    Supporters
    http://www.firstwordgroup.com/

    FirstWord is an innovative industry intelligence leader serving over 200,000 Pharma Professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 6.422.
    Drug Discovery Today will benefit your research by helping to keep you up-to-date with all of the fast-moving and emerging topics in drug discovery. Each issue is packed full of the latest research news, peer-reviewed articles and comment and opinion from leading research scientists.


    Drug Target Review

    Supporters
    http://www.drugtargetreview.com

    Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.


    Biocompare

    Supporters
    http://www.biocompare.com

    Biocompare is the most comprehensive, in-depth, and objective website for life science product information. Thousands of scientists use Biocompare daily to quickly find the right product for their experiments rather than looking through multiple print catalogs. Visit Biocompare to find the products you need, stay informed of new technologies, read product reviews, watch product videos, and keep up-to-date on life science news. Visit: www.biocompare.com


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


    PharmaVOICE

    Supporters
    http://www.pharmavoice.com

    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    One Nucleus

    Supporters
    http://www.onenucleus.com

    Established in May 2010, One Nucleus is the result of the merger of ERBI and London Biotechnology Network. One Nucleus is a not-for-profit membership organisation for international life science and healthcare companies and the largest of its kind in Europe. The company is based in Cambridge UK and London, at the heart of Europe's largest cluster. The 470 members include pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial Service Providers.


    BioChem Adda

    Supporters
    https://www.biochemadda.com/

    BioChem Adda is a Not-just-for-Profit organization which aims to bring out the most reliable and transparent information about everything related to jobs, careers, education, news, articles, and events from the field of BioSciences and Chemistry!


    BioPharm Insight

    Supporters
    http://www.infinata.com/biopharma-solution/by-product/biopharm-insight.html

    BioPharm Insight is your definitive guide to the global life sciences community. Subscribers take action on forward-looking intelligence uncovered by an independent team of investigative journalists, and make strategic business decisions using the most comprehensive and powerful real-time database of market analytics and key contacts. Featuring an intuitive online interface and exclusive Active IntelT relational content technology, BioPharm Insight provides an unrivaled capability to segment and analyze the industry with detailed and searchable profiles.


    Technology Networks

    Supporters
    http://www.technologynetworks.com

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    Copybook - Pharmaceutical

    Supporters
    http://www.copybook.com/pharmaceutical

    Copybook is a global business network with many pharmaceutical events, exhibitions and seminars. We encourage business-to-business transactions and work tirelessly to gain our customers new business contracts worldwide. You can add events, companies and associations for free. When you are a member, you can add your company to the events listed in order to encourage other visitors to arrange meetings and appointments at those events to facilitate new business contracts. Want to see how we can increase your business network and transactions? SIGN UP FOR FREE today! Copybook – Your Global Business Network


    Medical News Today

    Supporters
    http://www.medicalnewstoday.com

    Medical News Today is the largest independent medical and health news site on the web - with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.


    Farmavita

    Supporters
    http://www.farmavita.net/

    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    SelectScience

    Supporters
    http://www.selectscience.net/register?utm_source=Media-Partner&utm_medium=Website&utm_campaign=SMI

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover the latest drug discovery and development technologies, products and techniques with product reviews, videos, application notes and news articles. Become a member for free today.


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    Inderscience Publishers

    Supporters
    http://www.inderscience.com

    Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.


    EIN News

    Supporters
    http://www.einnews.com

    EIN News is the world leader in industry focused online news monitoring. Thousands of leading companies, institutions and global professionals from business, industry, and government rely on EIN News as an indispensable resource. Our systems continuously scan the web, indexing news from thousands of worldwide sources. The news you need is then organized by advanced software systems managed by a team of professional news editors. Everything we do is focused on streamlining your news searches and research in order to save you time and money.

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Holiday Inn Kensington Forum

    97 Cromwell Road
    London SW7 4DN
    United Kingdom

    Holiday Inn Kensington Forum

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.